Barbara Leary Pryor, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1350 E Arlington Blvd, Suite A, Greenville, NC 27858 Phone: 252-364-2806 Fax: 252-364-2863 |
Nicole Darden Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 910 Bremerton Dr, Greenville, NC 27858 Phone: 252-327-2244 Fax: 252-524-4674 |
Elizabeth Webb Carraway Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1925 Turnbury Dr, Greenville, NC 27858 Phone: 252-341-9944 |
Mrs. Cynthia Ann Taylor, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1925a Turnbury Dr, Greenville, NC 27858 Phone: 252-341-9944 Fax: 252-439-0957 |
News Archive
The Affordable Care Act on March 23 will reach a milestone many thought unlikely — it turns 10.
As in adults, migraine surgery is effective for selected adolescent patients with severe migraine headaches that don't respond to standard treatments, reports a study in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Argos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on the Arcelis technology platform, today announced that the NIH Division of AIDS (DAIDS) has approved $6.6 million in funding for an investigator-initiated Phase 2a adult eradication study of AGS-004, the company's investigational fully personalized immunotherapy for HIV.
Research led by Hernan A. Bazan, MD, Assistant Professor of Surgery, Section of Vascular Surgery, at LSU Health Sciences Center New Orleans School of Medicine, has found that unstable carotid artery plaques - those in danger of rupturing and leading to a stroke - contain more inflammation and significantly less omega-3 fatty acids than asymptomatic plaques.
Aeterna Zentaris Inc. today announced that the European Patent Office has granted a patent for the use of the ghrelin agonist, AEZS-130, related to methods and kits for use in relation to the diagnosis of growth hormone deficiency in a human or animal subject.
› Verified 3 days ago